Taiwan will expand its free pneumococcal vaccination program to include high-risk individuals aged 19 to 64 starting March 10 ...

As U.S. regulatory uncertainty swirls around the vaccine space and health care in general, Vaxcyte Inc. stands poised for a ...

Immune responses to PCV13 were blunted among infants who received the first vaccine dose during a respiratory viral season.

Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...

Completed Successful VAX-31 Phase 2 Adult Program; Company Remains on Track to Initiate VAX-31 Adult Phase 3 Pivotal, ...

The National Vaccine Committee has approved, in principle, the implementation of policies supporting local administrative ...